EKF Diagnostics Holdings plc (EKF) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
EKF Diagnostics revenues, gross profits fall as expected
20 March 2024 12:04
(Sharecast News) - EKF Diagnostics reported revenue of £52.6m in its final results on Wednesday, aligning with market projections, although lower than the prior year's figure of £66.6m.
-
Director dealings: EKF Diagnostics director raises stake
11 January 2024 15:11
(Sharecast News) - EKF Diagnostics revealed on Thursday that non-executive director Christopher Mills had acquired 100,000 shares in the AIM-listed global diagnostics business.
-
EKF Diagnostics cuts guidance after installation delays
12 September 2023 09:13
(Sharecast News) - Shares in EKF Diagnostics fell on Tuesday morning after the medical diagnostic products manufacturer warned that increasing its fermentation capacity is taking longer than planned, and...
-
EKF completes factory acceptance testing for huge new fermenter
20 June 2023 15:24
(Sharecast News) - EKF Diagnostics announced the successful completion of factory acceptance testing for its life sciences division's latest addition on Tuesday - a 14,500-litre enzyme fermenter.
-
EKF Diagnostics trading well as it progresses fermentation investment
17 May 2023 15:46
(Sharecast News) - EKF Diagnostics reported first-quarter trading that met expectations in an update on Wednesday, following the strong growth of its point-of-care and life sciences businesses in 2022.
-
EKF Diagnostics offloads ADL Health after strategic review
23 March 2023 14:01
(Sharecast News) - EKF Diagnostics announced the disposal of its subsidiary, Advanced Diagnostic Laboratory (ADL Health), on Thursday.
-
EKF announces details of Verici Dx share distribution
20 June 2022 09:41
(Sharecast News) - EKF Diagnostics announced the distribution of shares in its investment in Verici Dx on Monday, to its shareholders.
-
EKF gets cash payment for US inventory
13 June 2022 09:34
(Sharecast News) - EKF Diagnostics updated the market on its strengthening cash position on Monday, having disclosed £6.7m growth in working capital in its 2021 results, "particularly as a result of...
-
EKF Diagnostics making 'good' investment progress
18 May 2022 14:57
(Sharecast News) - EKF Diagnostics said in an update on Wednesday that it has already made "good progress" with its investment plans to support growth in the new financial year.
-
EKF confident even as Covid-related revenues wind down
29 March 2022 12:53
(Sharecast News) - EKF Diagnostics reported a 25% improvement in revenue in its final results on Tuesday, to £81.8m.
-
EKF Diagnostics invests another £2.5m in Verici Dx
7 March 2022 12:07
(Sharecast News) - EKF Diagnostics announced on Monday that it had invested in more than seven million placing shares in Verici Dx, for consideration of £2.5m.
-
EKF ends year ahead of already-upgraded expectations
25 January 2022 08:55
(Sharecast News) - Point-of-care, central laboratory device and chemistry reagent company EKF Diagnostics said on Tuesday that continued strong trading would result in its performance for 2021, including...
Company announcements Announcements
-
Half-year Report
17 September 2024 07:00
EKF Diagnostics Holdings
-
Notice of Results and Investor Presentation
3 September 2024 07:00
EKF Diagnostics Holdings
-
Trading Update
24 July 2024 07:00
EKF Diagnostics Holdings
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.